MIRUM PHARMAC. DL-,0001 (08D.DU)

Dusseldorf - Dusseldorf Delayed Price. Currency in EUR

21.60

+1.60

(+8.00%)

At close: 09:00PM CEST

Advertisement

Loading interactive chart...

Simply Wall St.
Market Sentiment Around Loss-Making Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM)
Mirum Pharmaceuticals, Inc. ( NASDAQ:MIRM ) is possibly approaching a major achievement in its business, so we would...
Zacks
Mirum's (MIRM) Livmarli Gets FDA Nod for Expanded Use, Stock Up
Mirum Pharmaceuticals (MIRM) announces FDA approval of Livmarli for infants 3 months and older. Stock up 6% in response to the news.
Business Wire
Mirum Announces Label Expansion for LIVMARLI in the United States to Include Infants Three Months of Age and Older
FOSTER CITY, Calif., March 14, 2023--Mirum Announces Label Expansion for LIVMARLI in the United States to Include Infants Three Months of Age and Older